Invitek offers non-GLP toxicology studies. Non-GLP toxicity studies intended to provide a preliminary assessment of a drug’s safety.

Non-GLP tox studies have the following advantage:

  • Performed on research grade materials
  • Gives the flexibility to design study protocol for regulatory submission
  • Reduces costs and time required for GMP grade material

GLP toxicology studies are required as part of the IND package before starting a human clinical trial.


In-Vivo Services

Route of Administration

Following standard routes of administration are offered

  • Oral (PO)
  • Intraperitoneal (IP)
  • Subcutaneous (SC)
  • Intravenous (IV)
  • Intramuscular (IM)
  • Topical

Toxicity Services

  • Maximum Tolerated Dose (MTD)
  • Acute Single Dose Toxicity
  • Repeat Dose Toxicity
  • Sub-Chronic Toxicity
  • Chronic Toxicity
  • Toxicokinetic


  • Bacterial Reverse Mutation (Ames) study
  • Chromosomal Aberration study
  • Mouse Micronucleus study

In-Vitro Services

  • Cytotoxicity
  • MTT Assays